A single-centre experience of febuxostat as a second-line urate-lowering therapy
ABSTRACTIntroduction: The purpose of this study was to describe the local experience in terms of drug efficacy and safety using a new xanthine oxidase inhibitor, febuxostat, as a second-line urate lowering therapy (ULT) in gout patients with normal renal function…
